Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTIRIN vs NASIC vs placebo in acute viral rhinitis
2005-005876-33Phase 3Completed
- Sponsor
- Zentiva
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of xylometazoline + dexpanthenol in rhinitis (3 arms), sponsored by Zentiva. Primary endpoint: Change in Total Nasal Symptom Score (TNSS) from baseline to Day 4. Started Mar 2006; status: completed.
02
Drugs
xylometazoline + dexpanthenol
03
Conditions
rhinitis
Beyond the preview
Go deeper on 2005-005876-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005876-33.